Crosstalk between programmed cell death in chondrocytes-a molecular mechanism of osteoarthritis

Kun Zhang1, Lianlin Zeng1, Huiqin Min2

  • 1Department of Rehabilitation Medicine, Suining Central Hospital, Suining, Sichuan Province, China.

Tissue & Cell
|September 30, 2025
PubMed

Insights

Programmed cell death (PCD) pathways are dysregulated in osteoarthritis (OA), impacting cartilage and joint health. Understanding these mechanisms, including apoptosis, necroptosis, and ferroptosis, is crucial for developing new OA treatments.

Area of Science:

  • Biomedical Science
  • Rheumatology
  • Cell Biology

Background:

  • Osteoarthritis (OA) is a chronic inflammatory disease characterized by cartilage degeneration and joint dysfunction.
  • Current OA treatments have limitations and significant adverse effects, necessitating novel therapeutic targets.
  • Programmed cell death (PCD) is increasingly recognized as a key factor in OA pathogenesis, particularly in chondrocytes and synoviocytes.

Purpose of the Study:

  • To analyze the mechanisms underlying osteoarthritis initiation and progression.
  • To summarize the regulatory roles of various programmed cell death (PCD) types in OA.
  • To identify novel therapeutic targets for OA treatment.

Main Methods:

  • Literature review and synthesis of existing research on PCD in OA.
  • Analysis of the roles of apoptosis, necroptosis, autophagy, NETosis, pyroptosis, ferroptosis, and cuproptosis in OA.
  • Discussion of PCD mechanisms in chondrocytes, synoviocytes, and other relevant cells.

Main Results:

  • Programmed cell death (PCD) pathways are significantly dysregulated in osteoarthritis (OA).
  • Specific PCD types, including apoptosis, necroptosis, autophagy, NETosis, pyroptosis, ferroptosis, and cuproptosis, play distinct regulatory roles in OA.
  • These PCD processes are implicated in the pathology of chondrocytes, synoviocytes, and other joint-resident cells.

Conclusions:

  • Dysregulated programmed cell death (PCD) is a critical component of osteoarthritis (OA) pathogenesis.
  • Understanding the multifaceted roles of different PCD pathways offers a vital theoretical basis for improving OA treatment.
  • Targeting specific PCD mechanisms presents a promising avenue for the development of novel OA therapeutics.

Related Concept Videos

Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
14.1K
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.9K
Growth of Cartilage and Bone Tissue01:27

Growth of Cartilage and Bone Tissue

Chondrocytes form a temporary cartilaginous model by dividing and secreting a thick gel-like extracellular matrix. Once the chondrocytes undergo programmed cell death, osteoblasts enter the site of the cartilaginous model. The process of replacing the temporary cartilaginous model with bone in an ordered manner is called endochondral ossification. In endochondral ossification, not all of the cartilage is replaced by bone tissue. Some cartilage that performs a protective and supportive function...
4.0K
Bone Formation by Endochondral Ossification01:24

Bone Formation by Endochondral Ossification

Bone formation, or ossification, begins around the sixth to seventh week of embryonic development. Most bones develop from a cartilaginous template through the process of endochondral ossification. Cartilage formation begins when clusters of mesenchymal cells differentiate into chondrocytes. These chondrocytes proliferate rapidly and secrete an extracellular matrix that becomes encased in a membrane called the perichondrium. The resulting cartilage model provides a template that resembles the...
8.4K
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
9.4K
Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
40.3K